
Emerging Tools for Alzheimer's Disease
Description
Emerging Tools for Alzheimer's Disease
Report Scope:
The report provides an overview of AD, and the current diagnostic methods. The report explains the need for emerging tools for the early detection of the disease. Tools that have been approved are discussed, as well as tools in the development phase. The report does not include therapeutics approved or in the pipeline for AD.
The report covers the global market for emerging tools with a look at the regional markets of North America, Europe and Emerging Markets.
The report provides a detailed analysis of the current and future global market for emerging tools. Industry growth drivers, restraints and opportunities are also discussed. The report also provides a look at the competitive landscape, profiles of companies developing tools for the early detection of AD, and the impact of COVID-19 on the market.
Report Includes:
An overview of the global market for emerging tools for the early detection of Alzheimer’s disease
Estimation of the market size and analyses of global market trends, with data from 2020 to 2022, estimates for 2023 with projections of compound annual growth rates (CAGRs) through 2028
Highlights of the current and future market potential and quantification of market based on type and region
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Detailed analysis of the regulatory framework and policies and product pipeline of the industry
Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
Companies Mentioned
AltPep
Araclon Biotech
C2N DIAGNOSTICS LLC
Cognoptix
Diadem Spa
F. HOFFMANN-LA ROCHE AG (ROCHE)
FUJIREBIO DIAGNOSTICS
QUANTERIX CORP.
QUEST DIAGNOSTICS INC.
SYSMEX CORP.
Table of Contents
51 Pages
- Chapter 1 Market Outlook
- 1.1 Market Snapshot
- Chapter 2 Executive Summary
- Chapter 3 Market Overview and Technology Background
- 3.1 Overview
- 3.2 Pathogenesis
- 3.3 Causes and Risk Factors
- 3.4 Diagnosis
- 3.5 Treatment
- Chapter 4 Emerging Tools and Technologies
- Chapter 5 Market Dynamics
- 5.1 Factors Affecting the Market for Emerging Tools for AD
- 5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Alzheimer's Disease
- 5.2.2 High Unmet Need
- 5.2.3 Need to Identify the Right Patients for Clinical Trials
- 5.2.4 Increasing Investments and Funding
- 5.3 Market Restraints
- 5.3.1 Technological Challenges
- 5.3.2 Ethical Challenges
- 5.3.3 Reimbursement Challenges
- 5.4 Opportunities
- 5.5 Impact of COVID-19
- Chapter 6 Emerging Tools for Alzheimer’s Disease
- 6.1 North America
- 6.2 Europe
- 6.3 Emerging Markets
- Chapter 7 Competitive Landscape and Analysis of Market Opportunities
- 7.1 Strategic Initiatives
- 7.2 Competitive Analysis
- Chapter 8 Company Profiles
- ALTPEP
- ARACLON BIOTECH
- C2N DIAGNOSTICS LLC
- COGNOPTIX
- DIADEM SPA
- F. HOFFMANN-LA ROCHE AG (ROCHE)
- FUJIREBIO DIAGNOSTICS
- QUANTERIX CORP.
- QUEST DIAGNOSTICS INC.
- SYSMEX CORP.
- Chapter 9 Project Scope and Methodology
- 9.1 Study Goals and Objectives
- 9.2 Reasons for Doing the Study
- 9.3 Scope of Report
- 9.4 Information Sources
- 9.5 Methodology
- 9.6 Market Breakdown by Region
- 9.7 Analyst's Credentials
- 9.8 BCC Custom Research
- 9.9 Related BCC Research Reports
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.